Study Reveals Protein Klotho Very Potentially Extends Up To 16 Years

Illustration of extraction of Chlotho protein (Freepic)

JAKARTA - Protein klotho is increasingly becoming a center of attention in scientific research because of its potential to slow down the aging process and extend life expectancy.

Recent research shows this protein is not only related to the length of life up to 16 years, but also plays an important role in maintaining body function as we age.

Klotho is produced naturally in the human body, especially in the kidneys and brain, and plays an important role in regulating metabolism, protecting cells from damage, and maintaining the health of vital organs.

Interestingly, scientists managed to extract a soluble version of this protein, which can then be injected into experimental animals. This is where research into the potential of Klotho as an extension therapy begins.

In an effort to understand the secrets of longevity, scientists around the world continue to explore various approaches, ranging from healthy lifestyles such as exercise and adequate sleep, to molecular approaches such as gene manipulation and the administration of certain proteins.

One of the salient studies was conducted by a team from the University of Barcelona and published by Medical Daily. In this study, experimental mice injected with Chlotho proteins showed an increase in life-age by up to 20 percent compared to mice who did not receive similar treatment.

The result is astonishing, the rat's lifetime increased from 26.3 months to 31.5 months. If converted into human age, this increase is equivalent to an additional 16 years from the average life expectancy set at 80 years.

Lebih dari sekadar memperpanjang usia, klotho juga terlihat memiliki efek perlindungan terhadap berbagai aspek perangan. Tiku yang mendapat protein ini menunjukkan penurunan yang lebih lambat pada kekuatan otoritas, kesehatan tulang, dan fung brain dibanding kelompok kontrol.

In addition, giving klotho proteins also contributes to better muscle regeneration and lowers the risk of muscle fibrossion, a condition where muscle tissue is damaged and the formation of scar tissue.

Although the results are promising, the researchers emphasize that the application of these findings to humans still requires in-depth follow-up studies. Strict clinical trials are needed to ensure safety, determine the right dose, and evaluate its long-term impact on the human body.

Given the significant biological differences between species, the results obtained on mice are not necessarily directly applicable to humans. However, these discoveries remain a major step towards a better understanding of aging and how we can manage it more effectively in the future.